Cossover CRU @ HUDERF

Inaugurated in 1986, Queen Fabiola Children's University Hospital (known by its French acronym as HUDERF) is the only Belgian university hospital entirely DEDICATED TO children's medicine designed specifically for them and for their parents. From birth to adolescence, the children receive the most complete care with respect to both in-patient and out-patient care.

 


As a medico-surgical hospital of 168 beds, HUDERF has more than 11,000 pediatric in-patients every year. The ambulatory sector (consultations and emergencies) is one of the most important in Belgium and receives more than 100,000 patients per annum.
HUDERF is also a public hospital (Brussels network IRIS) guaranteeing quality care and modern medicine accessible to all children.

Table 1 HUDERF Key Productivity Figures

Bed capacity Staff (FTEs) Traffic/year
HUDERF: 168 ±600 of whom ± 120 physicians Patient-contacts:     116,959 Hospitalizations:        11,000 Emergencies:            21,978  
 

The organization of healthcare provision is described in Table 2.

Table 2.  HUDERF Bed Structure

SurgeryPediatric Neonatal Intensive Care Unit Pediatric Intensive Care Unit Psychiatry (infants and young children)    Total
30902010 *18   168
 (*18 further beds planned in 2012)

Also –

One day pediatric surgical unit: 11 beds
One day pediatric medical unit: 8 beds
Pediatric dialysis unit: (6 beds) hemodialysis, peritoneal dialysis

HUDERF is the official reference centre for - 

  • Pediatric academic medicine of the Université Libre de Bruxelles
  • Hemodialysis and chronic kidney diseases
  • Cystic fibrosis
  • Allergy
  • Sleep disturbances
  • Non invasive ventilation
  • Extracorporeal Membrane Oxygenation
  • Diabetes
  • Cerebral palsy
  • Autism
  • Bone Marrow transplantation
  • Obesity
  • Neonatalogy
  • Inherited metabolic diseases
  • Deafness

Transplantations activities: 

  • bone marrow: about 11/yr
  • kidney (included if combined with liver or pancreas): about 5/yr
  • cardiac: about 1/yr


Many departments have various specialist clinics. HUDERF is a high-tech Healthcare Institution offering, with few exceptions, all diagnostic, therapeutic and preventive techniques available today.
Further details about HUDERF can be found on the Institution’s website.

For information about clinical research at HUDERF, click on the buttons below.


Crossover has developed a factbook about the clinical research potential of CHU Brugmann.
For a copy, please contact Jean-Pierre Tassignon, President & CEO (Jean-Pierre.Tassignon@crossover-cri.com).

top of page
  • Crossover has developed a
    clinical trials database
    for its partner hospitals
    and investigators ... more
  • Nathalie Vandenhoudt, PhD,
    Clinical Study Coordinator
    at the Crossover Clinical
    Research Unit in Brussels ... more
  • Crossover observes a
    continuing decline in
    industry-sponsored clinical
    trials.   Since ... more
  • 25-26 April 2012. Informa
    Life-Sciences’
    inaugural Risk-Based
    Approaches to Clinical ... more
  • 18-19 April 2012. 
    5th Annual CEE &
    CIS Clinical Trials Forum
    in Vienna   ... more
  • Lecture at the University
    of Neufchâtel,
    Switzerland  
    Jean-Pierre Tassignon, MD, ... more